COVID-19 has upended the status quo at U.S. healthcare organizations, requiring them to divert significant time and resources to mitigating the pandemic’s impact. This industry changing event risks distracting healthcare executives and frontline caregivers and potentially disturbing their longstanding value-based care efforts.
When COVID-19 hit Danville, Pa.-based Geisinger, the health system was working hard on an ongoing initiative to reduce hospital-acquired pressure injuries (HAPI) and central line-associated bloodstream infections (CLABSI) as a part of a unique provider-partner relationship with Medline Industries that has shared goals and outcomes. Even amid an unprecedented public health crisis, leaders at both organizations continued their intense focus on improving safety for patients. This paper explores how Geisinger and Medline leaders kept a focus on these critical goals during one of the most challenging public health crises in our nation’s history and discuss how the pandemic reinforced the partnership’s purpose and the need for value-based care.
